Article
New Orleans - Topical imiquimod (Aldara) treatment may play a role in preventing UVB-induced cutaneous immunosuppression, Anthony A. Gaspari, M.D., said at the annual meeting of the American Academy of Dermatology.
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: February 2-7
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Topical Corticosteroids: Potency, Vehicles, and Best Practices